MaxLinear
MXL
$63.46
-2.79%
MaxLinear, Inc. designs radio frequency and mixed-signal integrated circuits used in cable and satellite broadband communications, connected-home devices, and data center, metro, and long-haul fiber networks, competing in the highly cyclical semiconductor industry. Historically a niche supplier of RF receivers and system-on-chip solutions to broadband operators, the company has repositioned itself as a leveraged play on AI infrastructure through its optical and high-speed connectivity silicon, a shift that has fundamentally changed its investor identity. The current narrative is dominated by explosive growth in the Infrastructure segment, which now generates roughly half of revenue and is being fueled by AI data center optical interconnect demand, with headlines framing MaxLinear as a potential "next AI stock to 10X." That enthusiasm is tempered by a deeply uneven earnings record, a stock that has more than quadrupled over the past year yet remains roughly 44% below its 52-week high, and a valuation that leaves little room for execution missteps.…
MXL
MaxLinear
$63.46
Related headlines
Investment Opinion: Should I buy MXL Today?
Rating: Hold. The core thesis is that MaxLinear's AI infrastructure optical business is delivering genuine hyper-growth—55.17% year-over-year revenue growth in Q2 2026—but the stock's extreme volatility (beta 3.94), minimal free cash flow ($3.31 million), and valuation dependent on an unproven $3.68 forward EPS estimate create a risk/reward profile that is balanced at best. The analyst consensus is 'buy' with an average target of $94.55, implying 32.6% upside, but the wide target range of $40 to $125 signals low conviction and high uncertainty.
Supporting evidence for the Hold includes: the 3.23x trailing PS ratio is near the low end of the historical 9x-23x band, suggesting the stock is not historically stretched on sales; gross margin has expanded from 55.50% to 57.84% over five quarters, showing favorable mix; revenue has grown sequentially for four consecutive quarters from $126.46 million to $168.85 million; and the PEG ratio of 0.24 looks cheap if the forward estimates are achieved. However, the 12.61x EV/Sales and 76.9x price-to-cash-flow are rich, and the 0.2% FCF yield provides little fundamental support. The implied upside to the average target is meaningful but comes with a 3x spread in analyst targets.
The biggest risks that could invalidate the thesis are: (1) AI capex digestion causing Infrastructure revenue to decelerate, which would expose the thin profitability and minimal cash buffer; (2) continued multiple compression from 12.61x EV/Sales toward historical lows, especially with a beta of 3.94 amplifying market moves; and (3) failure to deliver the $3.68 forward EPS, which would make the stock expensive on virtually every cash-based measure. This Hold would upgrade to Buy if the stock pulls back to the $57-$59 support zone with stable fundamentals, or if free cash flow inflects meaningfully above $20 million annually. It would downgrade to Sell if revenue growth decelerates below 30% year-over-year or if the stock breaks below $57, confirming a lower-high/lower-low structure. Relative to its history and peers, the stock appears fairly valued on sales but expensive on cash flow, leaving little margin of safety.
Sign up to view all
MXL 12-Month Price Forecast
The forward-looking view is balanced between the genuine AI-driven revenue inflection and the extreme valuation and volatility risks. The bull case (25% probability) hinges on Infrastructure scaling to $1.36 billion and EPS reaching $3.93, while the base case (50%) assumes moderate growth toward $1.293 billion revenue and $3.68 EPS, supporting a $85-$100 target range. The bear case (25%) reflects AI capex digestion or competitive pressure driving the stock toward $40-$57. I would upgrade to bullish if free cash flow inflects above $20 million annually and operating margin turns sustainably positive, or if the stock pulls back to the $57-$59 support zone with intact fundamentals. I would downgrade to bearish if revenue growth decelerates below 30% year-over-year or if the stock breaks below $57, confirming a lower-high/lower-low structure.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MaxLinear's 12-month outlook, with a consensus price target around $93.91 and implied upside of +48.0% versus the current price.
Average Target
$93.91
0 analysts
Implied Upside
+48.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$40 - $125
Analyst target range
Coverage is solid for a $1.5 billion market cap, with 11 analysts and a consensus recommendation of "buy" (mean rating 1.82 on a 1-5 scale). The average target price of $94.55 implies roughly +32.6% upside from the current $71.32, and the consensus leans clearly bullish, with recent actions showing Roth Capital, Needham, and Stifel maintaining Buy ratings as of July 24, 2026, and Loop Capital upgrading from Hold to Buy on April 29, 2026. The bullish tilt is reinforced by the forward EPS estimate of $3.68 and revenue estimate of $1.293 billion, both of which assume the AI infrastructure ramp continues.
The target range is extremely wide — $40.00 to $125.00, a spread of more than 3x — signaling high uncertainty and low conviction in point estimates. The $125 high target assumes the AI optical business scales toward the $1.36 billion high-end revenue estimate and that operating leverage drives EPS toward $3.93, effectively pricing in multiple expansion on top of growth. The $40 low target discounts margin compression, competitive pressure in optical DSPs, or an AI capex digestion cycle that stalls the Infrastructure segment. Wells Fargo and Susquehanna remain at Equal Weight and Neutral respectively, reflecting skepticism about valuation, and the wide dispersion combined with a beta of 3.94 means investors should treat the consensus target as a directional signal rather than a precise price objective.
Drowning in data?
Find the real signal!
Bulls vs Bears: MXL Investment Factors
The bull case rests on a genuine revenue inflection—55.17% year-over-year growth in Q2 2026 driven by AI infrastructure optical demand—and a gross margin expansion to 57.84%, with analyst consensus buy and a $94.55 average target implying 32.6% upside. The bear case counters with extreme volatility (beta 3.94, max drawdown -55.28%), minimal free cash flow of $3.31 million, and a valuation entirely dependent on a forward EPS estimate of $3.68 that has yet to be proven. Currently, the bear evidence carries more weight near-term because the stock is in a clear distribution phase—down 8.77% in one session and 0.72% over three months versus SPY's 2.69% gain—despite the 308% one-year gain. The single most important tension is whether the AI optical infrastructure ramp can deliver the operating leverage implied by the forward EPS estimate; if it does, the stock is cheap on forward earnings, but if AI capex digestion stalls, the valuation has little support. This binary outcome, combined with a 3.94 beta, makes MXL a high-risk, high-reward proposition suited only for investors with strong risk tolerance.
Bullish
- Revenue inflecting violently upward: Q2 2026 revenue of $168.85 million grew 55.17% year-over-year versus $108.81 million in Q2 2025, marking the fourth consecutive sequential increase from $126.46 million in Q3 2025. This acceleration is driven by the Infrastructure segment, which contributed $85.02 million (roughly 50% of the quarter) and is fueled by AI data center optical interconnect demand.
- Gross margin expansion on favorable mix: Gross margin has expanded steadily from 55.50% in Q1 2025 to 57.84% in Q2 2026, reflecting a favorable mix shift toward higher-value infrastructure silicon. This 234-basis-point improvement over five quarters demonstrates pricing power and operating leverage as the AI optical business scales.
- Analyst consensus buy with 32.6% upside: The consensus recommendation is 'buy' (mean rating 1.82 on a 1-5 scale) from 11 analysts, with an average target price of $94.55 implying roughly +32.6% upside from the current $71.32. Recent actions include Loop Capital upgrading from Hold to Buy on April 29, 2026, and Roth Capital, Needham, and Stifel maintaining Buy ratings as of July 24, 2026.
- Forward EPS implies dramatic operating leverage: The forward PE of 27.29x against a $3.68 consensus EPS estimate implies the market expects a near-total earnings transformation from the current $0.02 GAAP EPS. If delivered, this would represent a massive inflection from the trailing losses of $45.14 million in Q1 2026 and $14.90 million in Q4 2025.
Bearish
- Extreme volatility and recent distribution: The stock fell 8.77% on the most recent session alone (from $78.18 to $71.32) and is down 0.72% over three months versus a 2.69% gain for SPY, producing a relative strength of -3.41. With a beta of 3.94 and a max drawdown of -55.28%, this name can unwind violently, as evidenced by the roughly 35% collapse in eight sessions from near $109 on October 6 to $71.32.
- Minimal free cash flow and weak profitability: Trailing free cash flow is only $3.31 million, a paltry 0.2% FCF yield on the $1.51 billion market cap, and the PCF ratio of 76.9x highlights how little cash the business throws off relative to its valuation. Operating margin remains negative at -2.48% because R&D of $56.03 million consumes 33% of revenue and stock-based compensation ran $27.48 million in the quarter.
- Valuation contingent on unproven forward estimates: The enormous gap between the negative trailing PE of -11.03x and the 27.3x forward multiple is the single most important valuation signal: the market is pricing a near-total earnings transformation. If the $3.68 forward EPS is not delivered, the stock is expensive on virtually every cash-based measure, including the 12.61x EV/Sales and 76.9x price-to-cash-flow.
- Wide analyst target dispersion signals low conviction: The target range is extremely wide—$40.00 to $125.00, a spread of more than 3x—signaling high uncertainty and low conviction in point estimates. Wells Fargo and Susquehanna remain at Equal Weight and Neutral respectively, reflecting skepticism about valuation, and the $40 low target discounts margin compression or an AI capex digestion cycle.
MXL Technical Analysis
MaxLinear is in a powerful but extraordinarily volatile uptrend: the stock is up 308.24% over the past year and 285.31% year-to-date, massively outpacing the S&P 500's 15.53% and 11.93% respective gains. At $71.32, the shares sit at roughly 50.8% of the 52-week range (low of $12.77, high of $128.30), meaning the stock has surrendered nearly half its peak-to-trough span despite the enormous annual gain — a signature of a momentum name that has already had its parabolic phase and is now digesting gains. This positioning is neither a clean breakout nor a falling knife; it reflects a market that has repriced the business upward but is now vigorously debating how much of the AI optical story is already in the price.
Short-term momentum is deteriorating sharply and diverging from the longer-term trend. The stock fell 8.77% on the most recent session alone (from $78.18 to $71.32) and is down 0.72% over three months versus a 2.69% gain for SPY, producing a relative strength of -3.41 over that window. The one-month change of +2.60% (relative strength +1.38) masks a violent intra-month path: the stock ran from $78.82 on October 14's prior levels near $109 on October 6 before collapsing roughly 35% in eight sessions. This divergence — a 308% one-year gain against a negative three-month return and a fresh 8.8% single-day drop — signals distribution and mean reversion rather than a healthy consolidation, and the -55.28% max drawdown underscores how quickly this name can unwind.
Key technical levels are well defined. Support sits at the 52-week low of $12.77, but far more relevant near-term support is the $57-$59 zone (the late-July/early-September lows), and a break below that would confirm a lower-high/lower-low structure and likely target the $40s. Resistance is the 52-week high of $128.30, with intermediate resistance at the $105-$109 area where the stock failed in early October; a decisive reclaim of $109 would signal the uptrend is resuming. With a beta of 3.94, MaxLinear is nearly four times as volatile as the market — a 1% SPY move implies roughly a 4% MXL move — which demands materially smaller position sizing and wider stops than a typical semiconductor holding.
Beta
3.94
3.94x market volatility
Max Drawdown
-55.3%
Largest decline past year
52-Week Range
$13-$128
Price range past year
Annual Return
+262.2%
Cumulative gain past year
| Period | MXL Return | S&P 500 |
|---|---|---|
| 1m | -24.7% | -1.0% |
| 3m | -11.4% | +2.9% |
| 6m | +5.2% | +6.5% |
| 1y | +262.2% | +13.1% |
| ytd | +242.8% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MXL Fundamental Analysis
Revenue is inflecting violently upward. Q2 2026 revenue of $168.85 million grew 55.17% year-over-year versus $108.81 million in Q2 2025, and marked the fourth consecutive sequential increase from $126.46 million in Q3 2025, $136.44 million in Q4 2025, and $137.19 million in Q1 2026. The segment mix explains the acceleration: Infrastructure contributed $85.02 million (roughly 50% of the quarter), Broadband $44.88 million, Connectivity $23.97 million, and Industrial/Multi-market $14.98 million, confirming that AI data center optical demand — not the legacy cable business — is the growth engine. Consensus estimates of $1.293 billion in forward revenue imply further acceleration from the current run-rate, which is the crux of the bull case and the key risk if AI capex digestion slows.
Profitability is thin but improving rapidly off a deeply loss-making base. Q2 2026 delivered net income of $1.76 million (EPS $0.02) and gross margin of 57.84%, up from a $45.14 million loss in Q1 2026 and losses of $14.90 million, $45.49 million, and $26.59 million across the prior three quarters. Gross margin has expanded steadily from 55.50% in Q1 2025 to 57.84% in Q2 2026, a favorable mix shift toward higher-value infrastructure silicon, yet operating margin remains negative at -2.48% because R&D of $56.03 million consumes 33% of revenue and stock-based compensation ran $27.48 million in the quarter. The company is only marginally profitable on a GAAP basis, and the gap between the $0.02 GAAP EPS and the $3.68 forward consensus EPS implies a dramatic operating leverage story that has yet to be proven.
Balance sheet health is adequate but cash generation is the weak link. Debt-to-equity is a manageable 0.348 with a current ratio of 1.34, and cash stood at $93.73 million at quarter-end, but trailing free cash flow is only $3.31 million — a paltry 0.2% FCF yield on the $1.51 billion market cap — and the PCF ratio of 76.9x highlights how little cash the business throws off relative to its valuation. ROE is -30.25% and ROA -4.89%, reflecting the trailing losses, while Q2 operating cash flow of just $4.81 million against $2.34 million of capex leaves almost nothing for buybacks or debt reduction. The company is funding growth internally but with minimal buffer, meaning any demand air-pocket would quickly force reliance on external financing.
Quarterly Revenue
$168847000.0B
2026-06
Revenue YoY Growth
+55.2%
YoY Comparison
Gross Margin
57.8%
Latest Quarter
Free Cash Flow
$3308000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MXL Overvalued?
Because trailing net income is negative (EPS of -$0.09, trailing PE of -11.03x), the PE ratio is not meaningful and I have selected the PS ratio as the primary metric, supplemented by EV/Sales given negative EBITDA (EV/EBITDA of -27.28x). MaxLinear trades at 3.23x trailing sales and 12.61x EV/Sales, while the forward PE of 27.29x against a $3.68 consensus EPS estimate implies the market expects a near-total earnings transformation — the enormous gap between the negative trailing PE and the 27.3x forward multiple is the single most important valuation signal in this dataset.
Relative to semiconductor peers, the picture is mixed depending on the metric. The 3.23x PS ratio is not extreme for a high-growth analog/mixed-signal name, but the 12.61x EV/Sales and 76.9x price-to-cash-flow are rich, and the 3.34x price-to-book sits above the 2.5x-3.0x range the stock has historically commanded. The PEG ratio of 0.24 looks cheap only because it is built on the aggressive forward EPS estimate; if that $3.68 figure is not delivered, the stock is expensive on virtually every cash-based measure. The premium is arguably justified by 55% revenue growth and AI infrastructure exposure, but it is a growth premium, not a profitability premium.
Historically, MaxLinear's PS ratio has ranged from roughly 9x to 23x over the past several years (23.3x in Q4 2021, 18.1x in Q4 2024, 11.1x in Q1 2026), so the current 3.23x trailing PS is actually near the low end of its own band — but that comparison is distorted because revenue has surged while the share price has not kept pace proportionally. On price-to-book, the current 3.34x is close to the 3.0x-3.4x levels seen through 2025, suggesting the market is pricing in continued execution rather than euphoria. The takeaway is that the stock is not historically stretched on sales, but its valuation is entirely contingent on the forward earnings ramp materializing.
PE
-11.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 21x~103x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-27.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. The company generated only $3.31 million in trailing free cash flow, a 0.2% FCF yield on a $1.51 billion market cap, and Q2 operating cash flow of $4.81 million against $2.34 million of capex leaves almost no buffer. Operating margin is -2.48% because R&D consumes 33% of revenue ($56.03 million) and stock-based compensation ran $27.48 million, while ROE is -30.25% and ROA -4.89%. Revenue concentration is a key vulnerability: the Infrastructure segment now generates roughly 50% of revenue ($85.02 million of $168.85 million), meaning any slowdown in AI data center optical demand would disproportionately impact the entire business. Additionally, the gap between $0.02 GAAP EPS and $3.68 forward consensus EPS implies a dramatic operating leverage story that has yet to be proven, and the company has a history of earnings volatility with losses of $45.14 million, $14.90 million, $45.49 million, and $26.59 million across recent quarters.
Market and competitive risks are elevated by the stock's extreme valuation sensitivity and volatility. With a beta of 3.94, MaxLinear is nearly four times as volatile as the market, meaning a 1% SPY move implies roughly a 4% MXL move, and the max drawdown of -55.28% underscores how quickly the name can unwind. The stock trades at 12.61x EV/Sales and 76.9x price-to-cash-flow, rich multiples that leave little room for execution missteps, and the 3.34x price-to-book sits above the 2.5x-3.0x range historically commanded. Competitive pressure in optical DSPs is a real threat, as the $40 low analyst target explicitly discounts margin compression or an AI capex digestion cycle. Recent news highlights the risk: a Motley Fool article notes the stock gained 50.7% last month but warns the lofty valuation and volatility make it a high-risk bet, while another piece frames MaxLinear as a potential 'next AI stock to 10X,' reflecting speculative enthusiasm that could reverse quickly.
The worst-case scenario would be a chain of events where AI data center capex slows, causing Infrastructure revenue to decelerate from its current 55% growth trajectory, which would expose the company's thin profitability and minimal cash buffer. This would likely trigger a valuation compression from 12.61x EV/Sales toward the lower end of its historical range, and with a beta of 3.94, the stock could easily retest its 52-week low of $12.77—a decline of approximately 82% from the current $71.32. Even a less severe scenario, such as a drop to the $40 analyst low target, would represent a 44% loss. The -55.28% max drawdown is a realistic historical reference, implying a decline to roughly $31.90 from current levels, and the recent 35% collapse in eight sessions from near $109 demonstrates how rapidly such a move can occur.
FAQ
The most severe risk is AI capex digestion, which could cause Infrastructure revenue (50% of total) to decelerate and expose the company's thin profitability and $3.31 million free cash flow. Second is valuation compression: at 12.61x EV/Sales, any slowdown could trigger a multiple reset toward historical lows, and with a beta of 3.94, the stock could easily retest its 52-week low of $12.77. Third is competitive pressure in optical DSPs, which could compress gross margins below 55% and invalidate the $3.68 EPS estimate. Fourth is execution risk: the company has a history of earnings volatility with losses of $45.14 million and $14.90 million in recent quarters, and failure to deliver on forward estimates would likely trigger analyst downgrades.
The 12-month forecast has three scenarios: a bull case (25% probability) targeting $110-$125 if Infrastructure scales to $1.36 billion and EPS reaches $3.93; a base case (50% probability) targeting $85-$100 if revenue tracks toward $1.293 billion and EPS toward $3.68; and a bear case (25% probability) targeting $40-$57 if AI capex digestion stalls growth. The base case is most likely, anchored by the analyst average target of $94.55, and assumes continued but moderating growth with stable gross margins around 57-58%. The key assumption is that AI data center optical demand remains robust through 2027.
MXL is fairly valued on sales but expensive on cash flow. The 3.23x trailing PS ratio is near the low end of its historical 9x-23x range, suggesting the stock is not stretched on revenue, but the 12.61x EV/Sales and 76.9x price-to-cash-flow are rich. The forward PE of 27.29x against a $3.68 EPS estimate implies the market expects a near-total earnings transformation from the current $0.02 GAAP EPS. If that estimate is delivered, the stock is reasonably priced; if not, it is expensive on virtually every cash-based measure. The market is pricing in continued hyper-growth and operating leverage, leaving little margin of safety.
From a risk/reward perspective, MXL is a speculative buy only for investors with high risk tolerance and a long time horizon. The analyst consensus target of $94.55 implies 32.6% upside, and the 55.17% revenue growth is genuine, but the stock's beta of 3.94 and max drawdown of -55.28% mean it can lose half its value in a downturn. The biggest downside risk is AI capex digestion, which could push the stock toward the $40 analyst low target, a 44% decline. For aggressive investors, a small position with a stop below $57 could offer asymmetric upside if the AI optical ramp continues, but conservative investors should avoid this name given its minimal free cash flow and negative operating margin.
MXL is better suited for long-term holding (minimum 2-3 years) by investors who can tolerate extreme volatility, given its beta of 3.94 and max drawdown of -55.28%. The company is in a growth stage with negative GAAP earnings and no dividend, so total return depends entirely on capital appreciation. Short-term trading is extremely risky due to the stock's violent swings—it fell 35% in eight sessions from near $109 to $71.32—and the wide analyst target range of $40-$125 signals low conviction. A suggested minimum holding period of 2-3 years allows time for the AI optical ramp to materialize and for operating leverage to drive EPS toward the $3.68 consensus estimate.